Market Movers | Winners: EMAT, MARA, TRON | Losers: AAP, MRNA, CAPR
A day of sharp declines and isolated gains raises the question of which moves have staying power.
Advance Auto Parts (AAP) closed down 24.5% on a day of broad market weakness. The S&P 500 returned -0.9%, the Dow Jones Industrial Average returned -1.3%, and the Nasdaq-100 returned -0.7%. The central question raised by such a steep, single-session decline is whether it reflects a new problem or an old one. The day’s full leaderboards follow.
Thursday’s Market Winners
The 6 stocks with the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | EMAT | Evolution Metals & Technologies | 16.8% | n/a |
| 2 | MARA | MARA | 15.5% | 24.2% |
| 3 | TRON | Tron | 15.4% | 50.8% |
| 4 | MRVI | Maravai LifeSciences | 14.8% | 155.1% |
| 5 | IOVA | Iovance Biotherapeutics | 12.5% | 229.3% |
| 6 | PRLD | Prelude Therapeutics | 12.5% | 124.1% |
Thursday’s Market Losers
And the 7 stocks with the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | AAP | Advance Auto Parts | -24.5% | 9.5% |
| 2 | MRNA | Moderna | -23.5% | 352.1% |
| 3 | CAPR | Capricor Therapeutics | -14.3% | -76.3% |
| 4 | LYTS | LSI Industries | -14.3% | 13.0% |
| 5 | EYPT | EyePoint | -14.3% | -70.4% |
| 6 | SPRY | ARS Pharmaceuticals | -13.7% | -52.7% |
| 7 | AIAI | AIAI | -13.3% | n/a |
Some of today’s losses have been building for weeks.
While many names on the daily lists are fresh, some are not. Capricor Therapeutics (CAPR) and EyePoint (EYPT) appear on both the one-day and one-month losers lists. The one-month return for CAPR is -63.9%, while EYPT shows a one-month return of -57.3%. For these stocks, today’s move is part of a much longer story of negative performance.
Movers Over The Last Week
Widening the window to five trading days, these are the strongest and weakest Market names:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | MRNA | Moderna | 109.5% | 352.1% |
| 2 | AMLX | Amylyx Pharmaceuticals | 76.4% | 228.3% |
| 3 | CAPR | Capricor Therapeutics | 62.4% | -76.3% |
| 4 | HTFL | HeartFlow | 50.9% | 60.5% |
| 5 | PURR | Hyperliquid Strategies | 47.8% | 183.1% |
| 6 | EMAT | Evolution Metals & Technologies | 47.3% | n/a |
| 7 | ETON | Eton Pharmaceuticals | 46.8% | 254.3% |
| 8 | MRVI | Maravai LifeSciences | 43.4% | 155.1% |
| 9 | ARCT | Arcturus Therapeutics | 39.8% | 79.3% |
| 10 | IVVD | Invivyd | 38.7% | -61.5% |
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | EYPT | EyePoint | -59.9% | -70.4% |
| 2 | KLC | KinderCare Learning Companies | -42.4% | -35.6% |
Movers Over The Last Month
And over the last 21 trading days:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | MRNA | Moderna | 129.6% | 352.1% |
| 2 | AMLX | Amylyx Pharmaceuticals | 124.1% | 228.3% |
| 3 | TEAM | Atlassian | 104.8% | 7.9% |
| 4 | RCEL | AVITA Medical | 104.3% | 192.5% |
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | MPLT | MapLight Therapeutics | -68.2% | -36.1% |
| 2 | CAPR | Capricor Therapeutics | -63.9% | -76.3% |
| 3 | EYPT | EyePoint | -57.3% | -70.4% |
A big move is a starting point, not a conclusion.
The tables earlier in this report are a map of market attention, not a set of instructions. A large daily return flags a stock where risk and opinion have changed quickly. The disciplined follow-up is to look past the percentage change and examine the business itself. For a name like Advance Auto Parts (AAP), we know its revenue declined 3.1% over the last twelve months, offering a piece of fundamental context for its move.
The next step is never to trade the list; it is to test it. Our Guidance Momentum screen shows which risers have management raising guidance behind them, and our Buy the Dip screen shows which of the fallers still generate the growth and cash that make a recovery plausible.
The Tape Rewards Attention. It Punishes Reaction
Big daily moves pull hard at both greed and fear, and acting on either, day after day, is how most portfolios end up trailing the index they were trying to beat.
The Trefis High Quality (HQ) Portfolio is built for the opposite reflex: about 30 quality businesses screened for the fundamentals that survive volatile stretches, held with rules instead of reactions. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Read the movers daily; trade them rarely.